AstraZeneca said on Tuesday it has submitted a request with a health regulator a.s.
To authorize emergency use for new care to prevent Covid-19.
British drug makers said in August that treatment, antibody therapy called AZD7442, had reduced the risk of people who developed the symptoms of Covid-19 of 77% in the final trial.
AstraZeneca file for our drug approval to prevent Covid-19
